{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:48:30Z","timestamp":1774687710531,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01863-2","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T14:47:18Z","timestamp":1755182838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The baseline 18F-FDG PET\/CT imaging features in pediatric patients with congenital neuroblastoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Keyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jigang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"issue":"3","key":"1863_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2174\/1573396311666150714105220","volume":"11","author":"RB Interiano","year":"2015","unstructured":"Interiano RB, Davidoff AM. Current management of neonatal neuroblastoma. Curr Pediatr Rev. 2015;11(3):179\u201387.","journal-title":"Curr Pediatr Rev"},{"issue":"23","key":"1863_CR2","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMra0804577","volume":"362","author":"JM Maris","year":"2010","unstructured":"Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362(23):2202\u201311.","journal-title":"N Engl J Med"},{"issue":"1","key":"1863_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.pcl.2014.09.015","volume":"62","author":"MS Irwin","year":"2015","unstructured":"Irwin MS, Park JR. Neuroblastoma: paradigm for precision medicine. Pediatr Clin N Am. 2015;62(1):225\u201356.","journal-title":"Pediatr Clin N Am"},{"issue":"1","key":"1863_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.hoc.2009.11.011","volume":"24","author":"JR Park","year":"2010","unstructured":"Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin N Am. 2010;24(1):65\u201386.","journal-title":"Hematol Oncol Clin N Am"},{"issue":"17","key":"1863_CR5","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1200\/JCO.22.01946","volume":"41","author":"HG Bender","year":"2023","unstructured":"Bender HG, Irwin MS, Hogarty MD, Castleberry R, Maris JM, Kao PC, et al. Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children\u2019s Oncology Group Risk Stratification. J Clin Oncol. 2023;41(17):3149\u201359.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1863_CR6","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.21037\/tp-24-319","volume":"13","author":"WB London","year":"2024","unstructured":"London WB, Bousquet H, Irwin MS, Hogarty MD, Cohn SL. Improvements in Children\u2019s Oncology Group neuroblastoma risk stratification through a change in age cut-off and use of INRGSS. Transl Pediatr. 2024;13(10):1899\u2013901.","journal-title":"Transl Pediatr"},{"issue":"33","key":"1863_CR7","doi-asserted-by":"publisher","first-page":"8483","DOI":"10.1200\/JCO.2005.02.4661","volume":"23","author":"G Cecchetto","year":"2005","unstructured":"Cecchetto G, Mosseri V, De Bernardi B, Helardot P, Monclair T, Costa E, et al. Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol. 2005;23(33):8483\u201389.","journal-title":"J Clin Oncol"},{"issue":"15","key":"1863_CR8","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1200\/JCO.2009.27.0421","volume":"28","author":"MA Smith","year":"2010","unstructured":"Smith MA, Seibel NL, Altekruse SF, Ries LA, Melbert DL, O\u2019Leary M, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol. 2010;28(15):2625\u201334.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1863_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/SLA.0b013e31826cbbbd","volume":"256","author":"JG Nuchtern","year":"2012","unstructured":"Nuchtern JG, London WB, Barnewolt CE, Naranjo A, McGrady PW, Geiger JD, et al. A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children\u2019s Oncology Group study. Ann Surg. 2012;256(4):573\u201380.","journal-title":"Ann Surg"},{"issue":"1","key":"1863_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/pbc.25218","volume":"62","author":"R Salloum","year":"2015","unstructured":"Salloum R, Garrison A, von Allmen D, Sheridan R, Towbin AJ, Adams D, et al. Relapsed perinatal neuroblastoma after expectant observation. Pediatr Blood Cancer. 2015;62(1):160\u201362.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1863_CR11","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.acra.2023.07.018","volume":"31","author":"L Feng","year":"2024","unstructured":"Feng L, Zhou Z, Liu J, Yao S, Wang C, Zhang H, et al. based radiomics nomogram for prediction of bone marrow involvement in pediatric neuroblastoma: a two-center study. Acad Radiol. 2024;31(3):1111\u201321.","journal-title":"Acad Radiol"},{"issue":"11","key":"1863_CR12","doi-asserted-by":"publisher","first-page":"7125","DOI":"10.1007\/s00330-024-10781-w","volume":"34","author":"X Lu","year":"2024","unstructured":"Lu X, Li C, Wang S, Yin Y, Fu H, Wang H, et al. The prognostic role of (18)F-FDG PET\/CT-based response evaluation in children with stage 4 neuroblastoma. Eur Radiol. 2024;34(11):7125\u201335.","journal-title":"Eur Radiol"},{"issue":"6","key":"1863_CR13","doi-asserted-by":"publisher","first-page":"e229022","DOI":"10.1148\/rycan.229022","volume":"4","author":"E Tran","year":"2022","unstructured":"Tran E, Joe BN. Potential prognostic value of FDG PET\/CT-derived intratumoral metabolic heterogeneity in neuroblastoma. Radiol Imag Cancer. 2022;4(6):e229022.","journal-title":"Radiol Imag Cancer"},{"issue":"5","key":"1863_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10585-024-10286-2","volume":"41","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Yang C. Predictive value of 18 F-FDG PET\/CT versus bone marrow biopsy and aspiration in pediatric neuroblastoma. Clin Exp Metastasis. 2024;41(5):627\u201338.","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"1863_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.6004\/jnccn.2024.0040","volume":"22","author":"R Bagatell","year":"2024","unstructured":"Bagatell R, Park JR, Acharya S, Aldrink J, Allison J, Alva E, et al. Neuroblastoma, Version 2. 2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024;22(6):413\u201333.","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"1863_CR16","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00259-008-0826-x","volume":"35","author":"J Stauss","year":"2008","unstructured":"Stauss J, Franzius C, Pfluger T, Juergens KU, Biassoni L, Begent J, et al. Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imag. 2008;35(8):1581\u201388.","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"18","key":"1863_CR17","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJM198510313131802","volume":"313","author":"RC Seeger","year":"1985","unstructured":"Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985;313(18):1111\u201316.","journal-title":"N Engl J Med"},{"issue":"8","key":"1863_CR18","doi-asserted-by":"publisher","first-page":"e27819","DOI":"10.1002\/pbc.27819","volume":"66","author":"K Campbell","year":"2019","unstructured":"Campbell K, Shyr D, Bagatell R, Fischer M, Nakagawara A, Nieto AC, et al. Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. Pediatr Blood Cancer. 2019;66(8):e27819.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1863_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrc1014","volume":"3","author":"GM Brodeur","year":"2003","unstructured":"Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3(3):203\u201316.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1863_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.bbrc.2006.10.020","volume":"351","author":"JH Kang","year":"2006","unstructured":"Kang JH, Rychahou PG, Ishola TA, Qiao J, Evers BM, Chung DH. MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells. Biochem Biophys Res Commun. 2006;351(1):192\u201397.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1863_CR21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41588-023-01332-y","volume":"55","author":"V K\u00f6rber","year":"2023","unstructured":"K\u00f6rber V, Stainczyk SA, Kurilov R, Henrich KO, Hero B, Brors B, et al. Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome. Nat Genet. 2023;55(4):619\u201330.","journal-title":"Nat Genet"},{"issue":"16","key":"1863_CR22","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1038\/sj.onc.1208306","volume":"24","author":"PS White","year":"2005","unstructured":"White PS, Thompson PM, Gotoh T, Okawa ER, Igarashi J, Kok M, et al. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma. Oncogene. 2005;24(16):2684\u201394.","journal-title":"Oncogene"},{"issue":"1","key":"1863_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13052-023-01508-6","volume":"49","author":"J Li","year":"2023","unstructured":"Li J, Qi Z, Chen M, Wang J, Liu X. Clinical value of combined serum CA125, NSE and 24-hour urine VMA for the prediction of recurrence in children with neuroblastoma. Ital J Pediatr. 2023;49(1):102.","journal-title":"Ital J Pediatr"},{"issue":"8","key":"1863_CR24","doi-asserted-by":"publisher","first-page":"e28359","DOI":"10.1002\/pbc.28359","volume":"67","author":"V Moroz","year":"2020","unstructured":"Moroz V, Machin D, Hero B, Ladenstein R, Berthold F, Kao P, et al. The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. Pediatr Blood Cancer. 2020;67(8):e28359.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"1863_CR25","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s00431-023-04899-0","volume":"182","author":"DD Yang","year":"2023","unstructured":"Yang DD, Liu C, Gao J, Hu QJ, Liang Y, Liu J. Association of image-defined risk factors with clinical features, tumor biology, and outcomes in neuroblastoma: a single-center retrospective study. Eur J Pediatr. 2023;182(5):2189\u201396.","journal-title":"Eur J Pediatr"},{"issue":"14","key":"1863_CR26","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1002\/cam4.4653","volume":"11","author":"JX Wang","year":"2022","unstructured":"Wang JX, Cao ZY, Wang CX, Zhang HY, Fan FL, Zhang J, et al. Prognostic impact of tumor size on patients with neuroblastoma in a SEER-based study. Cancer Med. 2022;11(14):2779\u201389.","journal-title":"Cancer Med"},{"issue":"2","key":"1863_CR27","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00259-024-06915-3","volume":"52","author":"G Abikhzer","year":"2025","unstructured":"Abikhzer G, Treglia G, Pelletier-Galarneau M, Buscombe J, Chiti A, Dibble EH, et al. EANM\/SNMMI guideline\/procedure standard for [(18)F]FDG hybrid PET use in infection and inflammation in adults v2.0. Eur J Nucl Med Mol Imag. 2025;52(2):510\u201338.","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"8","key":"1863_CR28","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/s00247-021-05005-y","volume":"51","author":"AJ Sung","year":"2021","unstructured":"Sung AJ, Weiss BD, Sharp SE, Zhang B, Trout AT. Prognostic significance of pretreatment (18)F-FDG positron emission tomography\/computed tomography in pediatric neuroblastoma. Pediatr Radiol. 2021;51(8):1400\u201305.","journal-title":"Pediatr Radiol"},{"issue":"8","key":"1863_CR29","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.7150\/ijms.58263","volume":"18","author":"S Man","year":"2021","unstructured":"Man S, Yan J, Li J, Cao Y, Hu J, Ma W, et al. Value of pretreatment 18F-FDG PET\/CT in prognosis and the reflection of tumor burden: a study in pediatric patients with newly diagnosed neuroblastoma. Int J Med Sci. 2021;18(8):1857\u201365.","journal-title":"Int J Med Sci"},{"issue":"3","key":"1863_CR30","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.acra.2023.08.007","volume":"31","author":"G Wang","year":"2024","unstructured":"Wang G, Si Y, Liu J, Wang W, Yang J. Prognostic Value of Metabolic Parameters and Textural Features in Pretreatment (18)F-FDG PET\/CT of Primary Lesions for Pediatric Patients with Neuroblastoma. Acad Radiol. 2024;31(3):1091\u2013101.","journal-title":"Acad Radiol"},{"issue":"1","key":"1863_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40644-024-00718-3","volume":"24","author":"J Liu","year":"2024","unstructured":"Liu J, Ren Q, Xiao H, Li S, Zheng L, Yang X, et al. Whole-tumoral metabolic heterogeneity in (18)F-FDG PET\/CT is a novel prognostic marker for neuroblastoma. Cancer Imaging. 2024;24(1):72.","journal-title":"Cancer Imaging"},{"issue":"1","key":"1863_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2967\/jnumed.120.254110","volume":"62","author":"R Vali","year":"2021","unstructured":"Vali R, Alessio A, Balza R, Borgwardt L, Bar-Sever Z, Czachowski M, et al. SNMMI Procedure Standard\/EANM Practice Guideline on Pediatric (18)F-FDG PET\/CT for Oncology 1.0. J Nucl Med. 2021;62(1):99\u2013110.","journal-title":"J Nucl Med"},{"key":"1863_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-med-011514-023121","volume":"66","author":"CU Louis","year":"2015","unstructured":"Louis CU, Shohet JM. Neuroblastoma: molecular pathogenesis and therapy. Annu. Rev. Med. 2015;66:49\u201363.","journal-title":"Annu. Rev. Med"},{"issue":"9","key":"1863_CR34","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1200\/JCO.2007.12.3349","volume":"26","author":"B Hero","year":"2008","unstructured":"Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG, et al. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. J Clin Oncol. 2008;26(9):1504\u201310.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1863_CR35","doi-asserted-by":"publisher","first-page":"e589","DOI":"10.1097\/MPH.0000000000002226","volume":"44","author":"A Yamada","year":"2022","unstructured":"Yamada A, Kinoshita M, Kamimura S, Nakame K, Moritake H. A metastatic neuroblastic tumor in a 28-month-old boy: unusual spontaneous regression from neuroblastoma to ganglioneuroma?. J Pediatr Hematol Oncol. 2022;44(2):e589\u201392.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"1863_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.12998\/wjcc.v8.i2.436","volume":"8","author":"J Liu","year":"2020","unstructured":"Liu J, Wu XW, Hao XW, Duan YH, Wu LL, Zhao J, et al. Spontaneous regression of stage III neuroblastoma: A case report. World J Clin Cases. 2020;8(2):436\u201343.","journal-title":"World J Clin Cases"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01863-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01863-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01863-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:55:25Z","timestamp":1757458525000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01863-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1863"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01863-2","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"6 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the research Ethics Committee of Beijing Friendship Hospital, Capital Medical University. This retrospectively study was carried out in the accordance with Declaration of Helsinkiand, and informed consent was waived due to its retrospective nature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"330"}}